Hydralazine Hydrochloride Tablet
Product Images NDC 82804-197

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 82804-197). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label12 (Label12)

FDA Label Image

Hydralazinecamber1 (Hydralazinecamber1)

FDA Label Image

82804-197-30 (Image 01)

82804-197-30 (Image 01)
This text provides details about Hydralazine HCI 100mg Tablets, their appearance, manufacturer (Annora Pharma Pvt. Ltd.), storage instructions, and packaging information. It includes information such as the product ID, manufacturing location, NDC number, expiration date, and dosage. The tablets are orange, round, unscored, and each is debossed with 'H' on one side and '41' on the other. It also mentions to keep the medication out of the reach of children and provides contact details for the manufacturer.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.